Dr. Philipp Oberdoerffer's lab at Johns Hopkins University focuses on understanding how epigenetic mechanisms influence DNA repair processes, particularly in the context of cancer. The team investigates how specific protein variants, especially a histone called macroH2A1, affect the repair of single-stranded DNA lesions that can lead to mutations and cancer. This research aims to improve our understanding of cancer vulnerabilities and potentially enhance treatment strategies.

Dr. Arta Monir Monjazeb's lab at UC Davis focuses on understanding how obesity affects cancer treatment, specifically how it influences the effectiveness of radiotherapy. They study the mechanisms behind why obese cancer patients respond poorly to treatment, utilizing various mouse models to explore how obesity-related factors like the hormone leptin can alter cancer cell behavior and the immune response. By identifying these links, the lab aims to develop improved treatment strategies for obese cancer patients and contribute to personalized medicine.

Dr. Adrian Lynn Oblak's research lab focuses on understanding how environmental factors, particularly air pollution and certain fungi, influence the development and progression of Alzheimer's disease (AD). The lab investigates the role of peripheral immune cells, which are crucial in responding to pollutants, in exacerbating AD neuropathology. Through their studies, they aim to identify potential biological mechanisms that connect lung health and brain function, with the goal of finding ways to mitigate the impacts of these exposures on Alzheimer's disease.

The research lab led by Dr. Ki Sueng Choi focuses on improving the treatment of severe obsessive-compulsive disorder (OCD) through advanced techniques like deep brain stimulation (DBS). By utilizing a detailed mapping of brain pathways, the lab aims to enhance the precision of this treatment, making it more effective for individuals. They are working to develop tools that can help clinicians better target the specific brain areas involved in OCD, ultimately improving patient outcomes.

Dr. Michael W. Jenkins' lab focuses on understanding how the nervous system controls the ocular surface, which is essential for maintaining eye health and function. The research involves studying the complex interactions between nerves, immune responses, and the structures of the eye, particularly in conditions that affect eye lubrication and sensation. By using advanced imaging techniques and animal models, the lab aims to uncover the underlying mechanisms of eye disorders and explore potential treatment options.

Dr. Neeraj J Gandhi's lab at the University of Pittsburgh focuses on understanding how our brains process and respond to moving targets, particularly how we accurately intercept them with our eye movements. By studying the complex neural mechanisms involved in oculomotor control, the lab aims to uncover important insights into neurological disorders that affect eye movements and motor coordination. This research has potential implications for diagnosing and treating conditions like mild traumatic brain injury and other neuropsychiatric disorders.

Dr. Georg Oeltzschner's lab at Johns Hopkins focuses on improving the accuracy of non-invasive brain measurements using magnetic resonance spectroscopy (MRS). The team develops cutting-edge statistical models to analyze biochemical data from the brain, particularly in the context of cancer research. Their goal is to ensure that these methods can reliably capture the complexity of biological data to aid in diagnosing and monitoring treatment responses in diseases affect the brain.

Dr. Negar Omidvari's lab at UC Davis focuses on understanding long-term health problems that some COVID-19 survivors face. They are using advanced imaging techniques to study how the immune system is affected by these lingering symptoms. By exploring the connections between immune responses, imaging data, and patient experiences, the lab aims to improve our understanding of these complex issues and help develop better treatments.

Dr. Marisa Elena Domino's lab at Arizona State University focuses on improving the treatment quality for people with opioid use disorder (OUD). The team works to understand how factors like race, gender, and age affect the quality of care patients receive. By analyzing real-time Medicaid claims data, they aim to uncover disparities in treatment and develop strategies to make opioid care more equitable and effective for everyone.

Dr. Liping Tang's lab focuses on advancing imaging techniques for diagnosing and monitoring infections related to orthopedic implants. Their innovative research develops new radiotracers based on D-amino acids to improve accuracy in identifying both Gram-positive and Gram-negative bacterial infections. Through both in vitro and in vivo studies, the lab aims to enhance precision in clinical settings, ultimately ensuring better patient outcomes in orthopedic healthcare.

Dr. Feliks Kogan's research lab at Stanford University focuses on innovative imaging techniques for studying osteoarthritis (OA), a condition impacting millions by causing pain and disability. The lab aims to develop new non-invasive MRI methods to assess inflammation in joints without needing contrast agents, helping to understand and monitor the disease better. They also explore how physiological stress affects joint response and metabolism, particularly across different ages and sexes, to improve early detection and treatment strategies for OA.

Dr. Zhiliang Cheng's lab at the University of Pennsylvania focuses on developing innovative treatments for osteoarthritis (OA), which is a debilitating joint disease. The lab aims to create dual-action nanoparticles that can effectively deliver therapies to restore cartilage health and reduce joint pain. By using both in vitro and animal models, the research aims to provide solutions that may improve the quality of life for those affected by OA and other degenerative joint diseases.

Dr. Melissa Grunlan's lab focuses on developing innovative treatments for osteochondral defects, which involve damage to cartilage and bone in joints. They aim to create a bioprosthetic implant that combines a synthetic cartilage cap with a biodegradable bone scaffold to enhance healing and restore joint function. This research is critical for improving patient outcomes in those suffering from joint pain and osteoarthritis.

Dr. Geeta Mehta's lab focuses on understanding the early stages of ovarian cancer, specifically how mutated cells from the fallopian tubes migrate and form tumors. The lab uses innovative microfluidic devices and bioreactors to mimic the fluid environment around these cells, allowing them to study how fluid shear stress affects cell behavior, replication, and potential tumor formation. Their research aims to uncover new insights that could lead to better detection methods and therapies for ovarian cancer.

Dr. Nadine Hempel's lab focuses on understanding ovarian cancer, particularly how cancer cells respond to losing contact with their surroundings and how this affects their ability to spread (metastasize). They study a specific protein, RHOV, which plays a critical role in these processes and could be a target for new treatments. By identifying key genes and their signaling pathways, the lab aims to develop precision medicine strategies to improve survival rates for ovarian cancer patients.

Dr. Ariella Shikanov's lab focuses on developing innovative therapies to restore ovarian function in young women who suffer premature ovarian insufficiency, often due to cancer treatments. The research aims to enhance the delivery of cell-based therapies using immunoisolating capsules to prevent immune rejection. This work seeks to test the efficacy of these therapies in non-human primate models, paving the way for future clinical applications.

Dr. Gulin Oz's research lab focuses on understanding the long-term effects of COVID-19 on the brain, particularly how the disease impacts the central nervous system (CNS). By employing advanced imaging techniques such as MRI and spectroscopy, the lab aims to investigate the underlying biology of prolonged neurological symptoms experienced by COVID-19 survivors. This work seeks to provide insights that may lead to better care and treatment strategies for those affected by these lasting health issues.

Dr. Raul Padron's research lab focuses on understanding how muscles contract and relax, particularly through studying protein structures in skeletal and cardiac muscles. The lab employs advanced imaging techniques to explore the molecular mechanisms behind muscle relaxation, which is crucial for energy conservation. By investigating specific interactions within muscle proteins, Dr. Padron aims to reveal insights relevant to muscle diseases and the effects of therapeutic drugs.

Dr. Virginie Papadopoulou's lab focuses on developing innovative ultrasound-based therapies to enhance the treatment of chronic wounds, particularly those infected by tough-to-treat bacterial biofilms. By using advanced materials and techniques like phase-change contrast agents and therapeutic ultrasound, they aim to improve antibiotic delivery and effectiveness, reducing infection rates and promoting faster healing. This research has significant implications for public health, especially for individuals with conditions like diabetes that complicate wound healing.

Dr. Sung Jin Park's lab at Emory University is focused on creating advanced models of the sinoatrial node, which is crucial for heart rhythm control. By developing three-dimensional multicellular organoids that mimic the natural structure and function of the sinoatrial node, the lab aims to address heart rhythm disorders and improve therapies for patients. This research is significant as it seeks to design biological pacemakers that could lead to better treatment options for those suffering from sinoatrial node dysfunction.